Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2007 1
2009 1
2010 1
2013 1
2017 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
BCL-XL directly modulates RAS signalling to favour cancer cell stemness.
Carné Trécesson S, Souazé F, Basseville A, Bernard AC, Pécot J, Lopez J, Bessou M, Sarosiek KA, Letai A, Barillé-Nion S, Valo I, Coqueret O, Guette C, Campone M, Gautier F, Juin PP. Carné Trécesson S, et al. Among authors: souaze f. Nat Commun. 2017 Oct 24;8(1):1123. doi: 10.1038/s41467-017-01079-1. Nat Commun. 2017. PMID: 29066722 Free PMC article.
Mitochondria at Center of Exchanges between Cancer Cells and Cancer-Associated Fibroblasts during Tumor Progression.
Nocquet L, Juin PP, Souazé F. Nocquet L, et al. Among authors: souaze f. Cancers (Basel). 2020 Oct 17;12(10):3017. doi: 10.3390/cancers12103017. Cancers (Basel). 2020. PMID: 33080792 Free PMC article. Review.
Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulation.
Souazé F, Forgez P. Souazé F, et al. Peptides. 2006 Oct;27(10):2493-501. doi: 10.1016/j.peptides.2006.04.029. Epub 2006 Aug 4. Peptides. 2006. PMID: 16889873 Review.
Differential roles of Hath1, MUC2 and P27Kip1 in relation with gamma-secretase inhibition in human colonic carcinomas: a translational study.
Souazé F, Bou-Hanna C, Kandel C, Leclair F, Devallière J, Charreau B, Bézieau S, Mosnier JF, Laboisse CL. Souazé F, et al. PLoS One. 2013;8(2):e55904. doi: 10.1371/journal.pone.0055904. Epub 2013 Feb 11. PLoS One. 2013. PMID: 23409082 Free PMC article.
Neurotensin receptor 1 determines the outcome of non-small cell lung cancer.
Alifano M, Souazé F, Dupouy S, Camilleri-Broët S, Younes M, Ahmed-Zaïd SM, Takahashi T, Cancellieri A, Damiani S, Boaron M, Broët P, Miller LD, Gespach C, Regnard JF, Forgez P. Alifano M, et al. Among authors: souaze f. Clin Cancer Res. 2010 Sep 1;16(17):4401-10. doi: 10.1158/1078-0432.CCR-10-0659. Clin Cancer Res. 2010. PMID: 20810387 Free article.
The neurotensin receptor-1 pathway contributes to human ductal breast cancer progression.
Dupouy S, Viardot-Foucault V, Alifano M, Souazé F, Plu-Bureau G, Chaouat M, Lavaur A, Hugol D, Gespach C, Gompel A, Forgez P. Dupouy S, et al. Among authors: souaze f. PLoS One. 2009;4(1):e4223. doi: 10.1371/journal.pone.0004223. Epub 2009 Jan 19. PLoS One. 2009. PMID: 19156213 Free PMC article.
Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression.
Souazé F, Dupouy S, Viardot-Foucault V, Bruyneel E, Attoub S, Gespach C, Gompel A, Forgez P. Souazé F, et al. Cancer Res. 2006 Jun 15;66(12):6243-9. doi: 10.1158/0008-5472.CAN-06-0450. Cancer Res. 2006. PMID: 16778199 Free article.
Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas.
Souazé F, Viardot-Foucault V, Roullet N, Toy-Miou-Leong M, Gompel A, Bruyneel E, Comperat E, Faux MC, Mareel M, Rostène W, Fléjou JF, Gespach C, Forgez P. Souazé F, et al. Carcinogenesis. 2006 Apr;27(4):708-16. doi: 10.1093/carcin/bgi269. Epub 2005 Nov 19. Carcinogenesis. 2006. PMID: 16299383
Over-expression of neurotensin high-affinity receptor 1 (NTS1) in relation with its ligand neurotensin (NT) and nuclear beta-catenin in inflammatory bowel disease-related oncogenesis.
Bossard C, Souazé F, Jarry A, Bezieau S, Mosnier JF, Forgez P, Laboisse CL. Bossard C, et al. Among authors: souaze f. Peptides. 2007 Oct;28(10):2030-5. doi: 10.1016/j.peptides.2007.06.030. Epub 2007 Jul 25. Peptides. 2007. PMID: 17870207